Data as of Jul 25, 2026 · Based on 2,718,867 AI responses across 9,511 prompts · See how Parse measures this
Levitate Biolevitate.bio · Low evidenceLevitate.bio offers a software platform that uses Rosetta-based tools to help protein scientists design proteins, with coding skills optional and automated workflows to keep research focused. The platform includes a curated tool library, expert-guided applications (antibody engineering, protein therapeutics and diagnostics, vaccine design, enzyme engineering, etc.), and step-by-step design solutions. It emphasizes 100% private data, strong security, is wholly owned by the Rosetta Commons Foundation, and is trusted by 140 biopharmas including 13 of the top 20 global pharmas, with demos available.
Parse Score